BYSI
BeyondSpring Inc.
Key Financials
Net Income
$-1006000
↑ 91.0%
EPS (Diluted)
$-0.03
N/A
Total Liabilities
$49.9M
↑ 2.7%
Total Assets
$25.9M
↓ 24.4%
Shareholders' Equity
$-32161000.00
↑ 2.2%
Operating Income
$-8945000
↓ 2.2%
Cash & Equivalents
$7.8M
↑ 166.5%
Operating Cash Flow
$-19769000.00
↓ 20.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 4/8/2026 | View on SEC |
| 4 | 4/3/2026 | View on SEC |
| 4 | 4/3/2026 | View on SEC |
| 4 | 4/3/2026 | View on SEC |
| 4 | 4/3/2026 | View on SEC |
| 4 | 4/3/2026 | View on SEC |
| 4 | 4/3/2026 | View on SEC |
| 10-K | 3/25/2026 | View on SEC |
| 8-K | 3/25/2026 | View on SEC |
| SCHEDULE 13G/A | 2/17/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | BYSI |
| Company Name | BeyondSpring Inc. |
| CIK | 1677940 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| Phone | 646-528-4184 |